Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7354578
Method of tumor regression with VEGF inhibitors
granted -
US 7354939
Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
granted -
US 7351702
Caspase inhibitors and uses thereof
granted -
US 7348335
Compositions useful as inhibitors of JAK and other protein kinases
granted -
US 7345054
Heterocyclic inhibitors of ERK2 and uses thereof
granted -
US 7338961
Sphingosine kinase inhibitors
granted -
US 7335662
Substituted tricyclic compounds as protein kinase inhibitors
granted -
US 7329681
Inhibitors of IMPDH enzyme
granted -
US 7329642
β-2-glycoprotein is an inhibitor of angiogenesis
granted -
US 7329652
Diaminotriazole compounds useful as protein kinase inhibitors
granted -
US 7326712
Substituted tricyclic compounds as protein kinase inhibitors
granted -
US 7326713
Substituted tricyclic compound as protein kinase inhibitors
granted -
US 7323173
Methods for treating breast cancer using a mammary cell growth inhibitor
granted -
US 7323171
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction
granted -
US 7321063
Sulfonamide inhibitors of aspartyl protease
granted -
US 7320991
Analogs of thalidomide as potential angiogenesis inhibitors
granted -
US 7314885
Pyrrole compounds useful as kinase inhibitors
granted -
US 7312227
Compositions useful as inhibitors of JAK and other protein kinases
granted -
US 7312226
Substituted tricyclic compounds as protein kinase inhibitors
granted -
US 7306799
Use of VEGF inhibitors for treatment of eye disorders
granted -
US 7303747
Use of VEGF inhibitors for treatment of eye disorders
granted -
US 7304061
Heterocyclic inhibitors of ERK2 and uses thereof
granted -
US 7303748
Method of treating eye injury with local administration of a VEGF inhibitor
granted -
US 7304071
Protein kinase inhibitors and uses thereof
granted